Pediatrix Medical reports Q2 adjusted EPS 34c, consensus 31c

Reports Q2 revenue $504M, consensus $505.49M. “Our second quarter operating results exceeded our expectations and reflected stable patient volumes, improved payor mix, and operating efficiencies,” said James Swift, CEO. “Our previously discussed portfolio management plans are well underway and we expect to complete these plans by the end of 2024. We believe that these operating plans, our strengthening financial position, and our focus on hospital-based care and maternal-fetal medicine will benefit all of our stakeholders.”